Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, March 1998, p. 225-229, Vol. 5, No. 2
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Lipopolysaccharide from Nonvirulent
Ara+ Burkholderia pseudomallei Isolates Is
Immunologically Indistinguishable from Lipopolysaccharide from Virulent
Ara
Clinical Isolates
Narisara
Anuntagool,1
Pakamas
Intachote,1
Vanaporn
Wuthiekanun,2
Nicholas J.
White,2,3 and
Stitaya
Sirisinha1,4,*
Laboratory of Immunology, Chulabhorn Research
Institute,1
Department of Microbiology,
Faculty of Science,4 and
Faculty of
Tropical Medicine,2 Mahidol University, Bangkok,
Thailand, and
Nuffield Department of Clinical Medicine,
University of Oxford, Oxford, United Kingdom3
Received 14 July 1997/Returned for modification 21 October
1997/Accepted 15 December 1997
Different lines of evidence suggest that a discrepancy between the
distribution of Burkholderia (Pseudomonas) pseudomallei in
the environment and the distribution of the disease melioidosis is
attributable, at least in part, to phenotypic differences between clinical and some environmental isolates. Two antigenically and biochemically distinct biotypes have been described, only one of which
is virulent. In this study, lipopolysaccharides (LPSs) were extracted
by the proteinase K digestion method from a total of 214 B. pseudomallei isolates, and their immunoreactivities with sera
from patients with different clinical spectra and with other infections
were evaluated. With the exception of 4 isolates from a total of 214 tested, the sodium dodecyl sulfate-polyacrylamide gel electrophoresis
silver-staining profiles of the LPSs from the two biotypes showed
identical ladder patterns that were typical for smooth LPSs from other
gram-negative bacteria. The 210 isolates with typical LPS patterns (119 Ara
clinical, 13 Ara
soil, 70 Ara+ soil, and 8 reference National Type Culture Collection
strains) also exhibited similar immunoblot profiles against pooled sera from patients with melioidosis and hyperimmune mouse sera. Concordant findings were noted in the indirect enzyme-linked immunosorbent assay
with Ara
and Ara+ LPSs to coat the microtiter
plates. The LPSs of the different B. pseudomallei biotypes
appear antigenically indistinguishable. It is, therefore, unlikely that
this component is related to the virulence and pathogenicity of
B. pseudomallei.
*
Corresponding author. Mailing address: Department of
Microbiology, Faculty of Science, Mahidol University, Rama 6 Rd.,
Bangkok 10400, Thailand. Phone: 662 246 2358, ext. 6606. Fax: 662 644 5411. E-mail: scssr{at}mahidol.ac.th.
Clinical and Diagnostic Laboratory Immunology, March 1998, p. 225-229, Vol. 5, No. 2
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ekchariyawat, P., Pudla, S., Limposuwan, K., Arjcharoen, S., Sirisinha, S., Utaisincharoen, P.
(2005). Burkholderia pseudomallei-Induced Expression of Suppressor of Cytokine Signaling 3 and Cytokine-Inducible Src Homology 2-Containing Protein in Mouse Macrophages: a Possible Mechanism for Suppression of the Response to Gamma Interferon Stimulation. Infect. Immun.
73: 7332-7339
[Abstract]
[Full Text]
-
Tiyawisutsri, R., Peacock, S. J., Langa, S., Limmathurotsakul, D., Cheng, A. C., Chierakul, W., Chaowagul, W., Day, N. P. J., Wuthiekanun, V.
(2005). Antibodies from Patients with Melioidosis Recognize Burkholderia mallei but Not Burkholderia thailandensis Antigens in the Indirect Hemagglutination Assay. J. Clin. Microbiol.
43: 4872-4874
[Abstract]
[Full Text]
-
Cheng, A. C., Currie, B. J.
(2005). Melioidosis: Epidemiology, Pathophysiology, and Management. Clin. Microbiol. Rev.
18: 383-416
[Abstract]
[Full Text]
-
Nelson, M., Prior, J. L, Lever, M S., Jones, H. E, Atkins, T. P, Titball, R. W
(2004). Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol
53: 1177-1182
[Abstract]
[Full Text]
-
Utaisincharoen, P., Anuntagool, N., Limposuwan, K., Chaisuriya, P., Sirisinha, S.
(2003). Involvement of Beta Interferon in Enhancing Inducible Nitric Oxide Synthase Production and Antimicrobial Activity of Burkholderiapseudomallei-Infected Macrophages. Infect. Immun.
71: 3053-3057
[Abstract]
[Full Text]
-
Atkins, T., Prior, R. G., Mack, K., Russell, P., Nelson, M., Oyston, P. C. F., Dougan, G., Titball, R. W.
(2002). A Mutant of Burkholderia pseudomallei, Auxotrophic in the Branched Chain Amino Acid Biosynthetic Pathway, Is Attenuated and Protective in a Murine Model of Melioidosis. Infect. Immun.
70: 5290-5294
[Abstract]
[Full Text]
-
ANUNTAGOOL, N., NAIGOWIT, P., PETKANCHANAPONG, V., ARAMSRI, P., PANICHAKUL, T., SIRISINHA, S.
(2000). Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J Med Microbiol
49: 1075-1078
[Abstract]
[Full Text]
-
Kespichayawattana, W., Rattanachetkul, S., Wanun, T., Utaisincharoen, P., Sirisinha, S.
(2000). Burkholderia pseudomallei Induces Cell Fusion and Actin-Associated Membrane Protrusion: a Possible Mechanism for Cell-to-Cell Spreading. Infect. Immun.
68: 5377-5384
[Abstract]
[Full Text]
-
Steinmetz, I., Reganzerowski, A., Brenneke, B., Häussler, S., Simpson, A., White, N. J.
(1999). Rapid Identification of Burkholderia pseudomallei by Latex Agglutination Based on an Exopolysaccharide-Specific Monoclonal Antibody. J. Clin. Microbiol.
37: 225-228
[Abstract]
[Full Text]